Propiedad y actividad de insiders de Barinthus Biotherapeutics plc (BRNS): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.74 |
| Capitalización | $30M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-09 | Oxford Science Enterprises plc | U-Tender | 8,797,770 | $977K |
| 2026-09-09 | Wright Robin | D-Return | 18,604 | $79K |
| 2026-09-09 | Wright Robin | D-Return | 19,197 | $44K |
| 2026-09-09 | Wright Robin | D-Return | 19,516 | $46K |
| 2026-09-09 | Wright Robin | D-Return | 20,174 | $20K |
| 2026-09-09 | Wright Robin | D-Return | 48,256 | $5 |
| 2026-09-09 | Wright Robin | D-Return | 20,394 | $2 |
| 2026-09-09 | Wright Robin | D-Return | 34,328 | $584K |
| 2026-09-09 | Scheeren Joseph | D-Return | 23,000 | $2 |
| 2026-09-09 | Scheeren Joseph | D-Return | 34,328 | $584K |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $11.4M | $43.3M | $214.1M | $194.4M | $142.1M | $110.7M | $70.5M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $3.9M | $518000 | $11.7M | $18.0M | $7.9M | $7.1M | $1.3M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $16.2M | $47.9M | $226.8M | $213.0M | $156.9M | $125.7M | $77.8M |
| Inmovilizado Material | $2.8M | $2.8M | $9.1M | $15.7M | $19.4M | $11.8M | $5.2M |
| Fondo de Comercio | 0 | 0 | $12.6M | $12.2M | $12.2M | 0 | 0 |
| Activos Intangibles | 0 | 0 | $31.4M | $28.3M | $25.1M | $21.9M | $14.3M |
| Activos Totales | $19.0M | $50.7M | $280.7M | $270.2M | $214.5M | $160.3M | $98.2M |
| Cuentas por Pagar | $3.9M | $4.7M | $2.4M | $3.7M | $1.6M | $2.5M | $350000 |
| Deuda a Corto | 0 | 0 | $159000 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $5.8M | $7.6M | $11.2M | $12.2M | $12.6M | $15.7M | $10.0M |
| Deuda a Largo | 0 | $44.7M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $41.1M | $53.8M | $28.2M | $27.0M | $27.5M | $30.2M | $23.9M |
| Reservas | -$37.9M | -$57.7M | -$108.6M | -$103.2M | -$176.6M | -$237.7M | -$304.1M |
| Patrimonio Neto | -$22.4M | -$3.5M | $252.1M | $242.9M | $186.8M | $130.0M | $74.2M |
| Deuda Total | $1.8M | $46.4M | $7.2M | $8.8M | $13.0M | $12.0M | $11.3M |
| Deuda Neta | -$9.7M | $3.1M | -$206.8M | -$185.6M | -$129.1M | -$98.7M | -$59.2M |
| Capital Circulante | $10.5M | $40.3M | $215.6M | $200.8M | $144.3M | $110.1M | $67.8M |
Salud financiera
| Deuda / Patrimonio | 0.18 |
| Ratio corriente | 5.54 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -4.62 |
Rentabilidad
| Rentabilidad sobre capital | -59.18% |
| Rentabilidad sobre capital invertido | -61.15% |
| Rentabilidad sobre activos | -50.97% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ALGS · CVM · INMB · KPTI · KZR · MDCX · MRSN
Explorar sector: Healthcare · Biotechnology
Más secciones de BRNS: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones